Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
复制标题
基于透明细胞肾细胞癌患者新的铁死亡相关基因特征的总生存率预测
DOI:
10.1186/s12957-022-02555-9
复制
发表时间:
2022-04-14
影响因子:
3.2
通讯作者:
Wang, Hua
中科院分区:
文献类型:
--
作者:
Sun, Zhuolun;Li, Tengcheng;Xiao, Chutian;Zou, Shaozhong;Zhang, Mingxiao;Zhang, Qiwei;Wang, Zhenqing;Zhan, Hailun;Wang, Hua
Clear cell renal cell carcinoma (ccRCC) is the most common and lethal renal cell carcinoma (RCC) histological subtype. Ferroptosis is a newly discovered programmed cell death and serves an essential role in tumor occurrence and development. The purpose of this study is to analyze ferroptosis-related gene (FRG) expression profiles and to construct a multi-gene signature for predicting the prognosis of ccRCC patients. RNA-sequencing data and clinicopathological data of ccRCC patients were downloaded from The Cancer Genome Atlas (TCGA). Differentially expressed FRGs between ccRCC and normal tissues were identified using ‘limma’ package in R. GO and KEGG enrichment analyses were conducted to elucidate the biological functions and pathways of differentially expressed FRGs. Consensus clustering was used to investigate the relationship between the expression of FRGs and clinical phenotypes. Univariate and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis were used to screen genes related to prognosis and construct the optimal signature. Then, a nomogram was established to predict individual survival probability by combining clinical features and prognostic signature. A total of 19 differentially expressed FRGs were identified. Consensus clustering identified two clusters of ccRCC patients with distinguished prognostic. Functional analysis revealed that metabolism-related pathways were enriched, especially lipid metabolism. A 7-gene ferroptosis-related prognostic signature was constructed to stratify the TCGA training cohort into high- and low-risk groups where the prognosis was significantly worse in the high-risk group. The signature was identified as an independent prognostic indicator for ccRCC. These findings were validated in the testing cohort, the entire cohort, and the International Cancer Genome Consortium (ICGC) cohort. We further demonstrated that the signature-based risk score was highly associated with the ccRCC progression. Further stratified survival analysis showed that the high-risk group had a significantly lower overall survival (OS) rate than those in the low-risk group. Moreover, we constructed a nomogram that had a strong ability to forecast the OS of the ccRCC patients. We constructed a ferroptosis-related prognostic signature, which might provide a reliable prognosis assessment tool for the clinician to guide clinical decision-making and outcomes research. The online version contains supplementary material available at 10.1186/s12957-022-02555-9.
登录
查看更多内容
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
5.6
作者:
Lu B;Chen XB;Ying MD;He QJ;Cao J;Yang B
通讯作者:
Yang B
影响因子:
5.5
作者:
Liu, Han-jie;Hu, Hui-min;Jiang, Tao
通讯作者:
Jiang, Tao
影响因子:
64.8
作者:
Jiang, Le;Kon, Ning;Li, Tongyuan;Wang, Shang-Jui;Su, Tao;Hibshoosh, Hanina;Baer, Richard;Gu, Wei
通讯作者:
Gu, Wei
DOI:
10.1073/pnas.0910258107
发表时间:
2010-08-24
影响因子:
11.1
作者:
Clendening, James W.;Pandyra, Aleks;Penn, Linda Z.
通讯作者:
Penn, Linda Z.